Merck (MRK) Misses Q4 EPS by 6c, FY Guidance Tops Views
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $78.17 -0.31%
EPS Growth %: -6.7%
Financial Fact:
Net Income: 8.08B
Today's EPS Names:
PLTK, MIME, KRNT, More
EPS Growth %: -6.7%
Financial Fact:
Net Income: 8.08B
Today's EPS Names:
PLTK, MIME, KRNT, More
Trade Now!
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Merck (NYSE: MRK) reported Q4 EPS of $1.32, $0.06 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.68 billion.
GUIDANCE:
Merck sees FY2021 EPS of $6.48-$6.68, versus the consensus of $6.41. Merck sees FY2021 revenue of $51.8-53.8 billion, versus the consensus of $51.77 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NortonLifeLock Inc. (NLOK) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenues Guidance Above Consensus
- UWM Holdings Corporation (UWMC) Reports Q1 EPS of $0.33
- Castle Biosciences Inc. (CSTL) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
